Approximately 20% of individuals younger than age 50 who are diagnosed with colorectal cancer carry a germline mutation associated with cancer, despite having no clinical or family history of the disease.

Research in Review

Adding aspirin to cancer treatment regimens can reduce mortality by 20% in patients with colon cancer, according to a meta-analysis published in PLOS One.

Read More

Despite being widely accepted as the standard of care for locally advanced rectal cancer, neoadjuvant chemoradiation (NACRT) is only used in about half of US patients with the disease, according to a recent study.

Read More

Subscribe to Colorectal Cancer